The Research and Development team at Vigil Neuro is dedicated to advancing the company’s mission of developing innovative therapies for neurodegenerative diseases. This multidisciplinary team, consisting of experts in biology, chemistry, and clinical sciences, collaborates to discover and optimize microglia-targeted treatments. They leverage cutting-edge research and analytical methodologies to translate scientific discoveries into actionable therapies, ensuring a streamlined approach from the laboratory to clinical applications.